Literature DB >> 8764998

The structure of the lantibiotic lacticin 481 produced by Lactococcus lactis: location of the thioether bridges.

H W van den Hooven1, F M Lagerwerf, W Heerma, J Haverkamp, J C Piard, C W Hilbers, R J Siezen, O P Kuipers, H S Rollema.   

Abstract

The lantibiotic lacticin 481 is a bacteriocin produced by Lactococcus lactis ssp. lactis. This polypeptide contains 27 amino acids, including the unusual residues dehydrobutyrine and the thioether-bridging lanthionine and 3-methyllanthionine. Lacticin 481 belongs to a structurally distinct group of lantibiotics, which also include streptococcin A-FF22, salivaricin A and variacin. Here we report the first complete structure of this type of lantibiotic. The exact location of the thioether bridges in lacticin 481 was determined by a combination of peptide chemistry, mass spectrometry and NMR spectroscopy, showing connections between residues 9 and 14, 11 and 25, and 18 and 26.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8764998     DOI: 10.1016/0014-5793(96)00771-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  11 in total

1.  Lantibiotic biosynthesis: interactions between prelacticin 481 and its putative modification enzyme, LctM.

Authors:  P Uguen; J P Le Pennec; A Dufour
Journal:  J Bacteriol       Date:  2000-09       Impact factor: 3.490

2.  Generation of food-grade lactococcal starters which produce the lantibiotics lacticin 3147 and lacticin 481.

Authors:  Lisa O'Sullivan; Maire P Ryan; R Paul Ross; Colin Hill
Journal:  Appl Environ Microbiol       Date:  2003-06       Impact factor: 4.792

3.  Does double electron capture lead to the formation of biradicals? An ECD-SORI-CID study on lacticin 481.

Authors:  Anne J Kleinnijenhuis; Albert J R Heck; Marc C Duursma; Ron M A Heeren
Journal:  J Am Soc Mass Spectrom       Date:  2005-10       Impact factor: 3.109

4.  Salivaricin A2 and the novel lantibiotic salivaricin B are encoded at adjacent loci on a 190-kilobase transmissible megaplasmid in the oral probiotic strain Streptococcus salivarius K12.

Authors:  Otto Hyink; Philip A Wescombe; Mathew Upton; Nancy Ragland; Jeremy P Burton; John R Tagg
Journal:  Appl Environ Microbiol       Date:  2006-12-28       Impact factor: 4.792

5.  Covalent Structure and Bioactivity of the Type AII Lantibiotic Salivaricin A2.

Authors:  Mengxin Geng; Frank Austin; Ronald Shin; Leif Smith
Journal:  Appl Environ Microbiol       Date:  2018-02-14       Impact factor: 4.792

6.  Isolation and identification of a Paenibacillus polymyxa strain that coproduces a novel lantibiotic and polymyxin.

Authors:  Zengguo He; Duygu Kisla; Liwen Zhang; Chunhua Yuan; Kari B Green-Church; Ahmed E Yousef
Journal:  Appl Environ Microbiol       Date:  2006-10-27       Impact factor: 4.792

7.  Characterization of the lacticin 481 operon: the Lactococcus lactis genes lctF, lctE, and lctG encode a putative ABC transporter involved in bacteriocin immunity.

Authors:  A Rincé; A Dufour; P Uguen; J P Le Pennec; D Haras
Journal:  Appl Environ Microbiol       Date:  1997-11       Impact factor: 4.792

8.  Leader Peptide Establishes Dehydration Order, Promotes Efficiency, and Ensures Fidelity During Lacticin 481 Biosynthesis.

Authors:  Christopher J Thibodeaux; Joshua Wagoner; Yi Yu; Wilfred A van der Donk
Journal:  J Am Chem Soc       Date:  2016-05-10       Impact factor: 15.419

9.  In vitro mutasynthesis of lantibiotic analogues containing nonproteinogenic amino acids.

Authors:  Matthew R Levengood; Patrick J Knerr; Trent J Oman; Wilfred A van der Donk
Journal:  J Am Chem Soc       Date:  2009-09-02       Impact factor: 15.419

10.  Development and Application of Yeast and Phage Display of Diverse Lanthipeptides.

Authors:  Kenton J Hetrick; Mark C Walker; Wilfred A van der Donk
Journal:  ACS Cent Sci       Date:  2018-03-28       Impact factor: 14.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.